Anti-EphB2 Antibody represents a highly specialized monoclonal antibody specifically engineered to target the human ephrin type-B receptor 2 (EphB2) with exceptional binding affinity. It effectively facilitates the measurable blockade of EphB2-mediated forward signaling across various preclinical experimental models to evaluate the disruption of tumor cell migration and invasiveness during strictly monitored laboratory observation periods and functional cell survival assays.
Target:
Ephrin Receptor
T9901A-1274
* VAT and and shipping costs not included. Errors and price changes excepted
